GSA Capital Partners’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-47,595	Closed	-$75K	–	2026
2022 Q3	$75K	Buy	47,595 +26,074	+121%	+$59.1K	0.01%	1397
2022 Q2	$43K	Sell	21,521 -299,608	-93%	-$518K	0.01%	1300
2022 Q1	$748K	Buy	321,129 +286,428	+825%	+$893K	0.1%	308
2021 Q4	$161K	Sell	34,701 -662	-2%	-$4.11K	0.02%	1261
2021 Q3	$270K	Buy	+35,363	New	+$300K	0.03%	1085
2021 Q2	–	Sell	-25,808	Closed	-$213K	–	1697
2021 Q1	$213K	Buy	25,808 +7,390	+40%	+$78K	0.04%	865
2020 Q4	$126K	Buy	+18,418	New	+$148K	0.02%	1073
2018 Q3	–	Sell	-77,895	Closed	-$561K	–	1990
2018 Q2	$561K	Sell	77,895 -157,600	-67%	-$1.07M	0.03%	1098
2018 Q1	$1.21M	Buy	+235,495	New	+$1.68M	0.06%	535
2017 Q1	–	Sell	-17,019	Closed	-$83K	–	2063
2016 Q4	$83K	Buy	+17,019	New	+$102K	0.01%	1684
2016 Q1	–	Sell	-11,933	Closed	-$104K	–	1983
2015 Q4	$104K	Sell	11,933 -100,134	-89%	-$845K	0.01%	1736
2015 Q3	$940K	Buy	+112,067	New	+$1.79M	0.05%	685
2015 Q2	–	Sell	-25,889	Closed	-$299K	–	2247
2015 Q1	$299K	Buy	+25,889	New	+$300K	0.01%	1711